Donate

2020 Quantitative Imaging Workshop Materials

Quantitative Imaging Workshop XVII

General Workshop Documents

Agenda

Narrative Speaker Bios

2019 Meeting Report published in Translational Medicine Communications: Prevent Cancer Foundation quantitative CT imaging workshop XVI: lung cancer, COPD and cardiovascular disease – on the cusp of transformation, Arlington, VA

American Lung Association One-Pager


Workshop Video Content and Materials

Included below are the full session recordings accompanied by topic overview videos and slides for those speakers who used them. There were speakers and session topics for which presentation slides were not used.

Session One: Welcome, National Leadership Award & Keynote Address

Session Two: Value of Metrology

Session Three: Ensuring Health Equity in Lung Cancer Screening & Management

Session Four: Lung Cancer Screening & COPD – Clinical Interventions & Implications

Session Five: COPD & Small Lung Nodule – Technical Applications

Session Six: IELCART

Session Seven: Population Health Metrics – HEDIS & Stars

Virtual Breakout Sessions 


Session One: Welcome, National Leadership Award & Keynote Address

Welcome and Overview – James L. Mulshine, M.D., Rush University Medical Center

Welcome slides

James L. Mulshine, M.D. Leadership Award – Presentation to Dr. Daniel Sullivan

Foundation stories: 35 years of cancer research and impact

Keynote – Swatee Surve, MBA, MSME, Founder & Chief Executive Officer, Litesprite

Can We Use Games to Collect High Quality Data to Improve Health Outcomes for Screening-Detected Chronic Health Conditions?


Session Two: Value of Metrology

Topic 1: Clinical Perspective: What are the Challenges and Hurdles Hindering the Implementation of Advanced Image Analysis Tools for CT Screening?

Topic overview: Gregory Sorensen, MD, DeepHealth, Inc.

Panelist Slides

Ronald Summers, MD, PhD, National Institutes of Health Clinical Center

Eliot Siegel, MD, University of Maryland and VA Maryland Healthcare System and National Cancer Institute’s Cancer Image Archive

Curtis Langlotz, MD, PhD, Stanford University Medical Center

Topic 2: Metrology and Quality Assurance Perspective: What are the Challenges and Hurdles Hindering the Validation and Regulatory Approval of AI Algorithms for CT Screening?

Topic Overview:  Maryellen L. Giger, PhD, The University of Chicago

Panelist Slides

Nancy Obuchowski, PhD, Cleveland Clinic Foundation

Ricardo Avila, MS, Accumetra LLC

Anthony P. Reeves, PhD, School of Electrical and Computer Engineering, Cornell University

Timor Kadir, DPhil, MEng, Optellum (United Kingdom)


Session Three: Ensuring Health Equity in Lung Cancer Screening & Management

Topic 1: Addressing Health Equity in Vulnerable Communities

Topic Overview: Mary Pasquinelli, DNP, APRN, FNP-BC, University of Illinois Hospital and Health Science System

Panelist: Daniel Petereit, MD, Cancer Care Institute at Monument Health, Walking Forward: American Indian Cancer Disparity Program

Topic 2: Can Information Technologies Enhance Access to Health Information for Vulnerable Communities?

Topic Overview:  Garth Graham, MD, MPH, FACP, FACC, CVS Health  


Session Four: Lung Cancer Screening & COPD – Clinical Interventions & Implications

Topic 1: Technical Perspective: Can the Low Dose CT Scan Be Used as a Window to Early Lung Disease? 

Topic Overview:  Lee Gazourian, MD, Lahey Hospital & Medical Center

Panelist Slides

Marcus Chen, MD, Cardiothoracic CT Program, National Heart, Lung and Blood Institute

Mary Salvatore, MD, MBA, Division of Cardiothoracic Imaging, Columbia University Medical Center

Topic 2: Clinical Perspective: Moving to Pulmonary Disease Interception

Topic Overview: Gerard Criner, MD, FACP, FACCP, Lewis Katz School of Medicine, Temple University

Panelist Slides

Bartolome Celli, MD, FCCP, Chronic Obstructive Pulmonary Disease Center, Brigham and Women’s Hospital and Harvard Medical School

Barry Make, MD, Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health


Session Five: COPD & Small Lung Nodule – Technical Applications

Topic 1: Improving the Impact of the QIBA CT Small Lung Nodule Profile

Topic Overview:  Ricardo Avila, MS, Accumetra LLC

Panelist slides

Nancy Obuchowski, PhD, Cleveland Clinic Foundation

Raja Subramaniam, PhD, Icahn School of Medicine at Mount Sinai

Samuel Armato, PhD, The University of Chicago

Stephen Lam, MD, FRCPC, British Columbia Cancer Agency and Pan-Canadian Lung Cancer Screening Network (Canada)

Topic 2: Making Progress Toward a COPD & Small Lung Nodule Protocol

Topic Overview:  George R. Washko, MMSc, MD, Brigham and Women’s Hospital and Harvard Medical School

Panelist slides

Sean Fain, PhD, University of Wisconsin School of Medicine and Public Health  

Nicholas Petrick, PhD, Division of Imaging, Diagnostics and Software Reliability, US Food and Drug Administration


Session Six: IELCART

IELCART Update on Lung Cancer Screening Innovations

Claudia I. Henschke, PhD, MD, Icahn School of Medicine at Mount Sinai

Treatment of Early Stage Lung Cancer and How to Identify Which Cancers are Most Curable Versus Those Likely to Recur

Topic Overviews

David Yankelevitz, MD, Icahn School of Medicine at Mount Sinai

Nasser K. Altorki, MD, Division of Thoracic Surgery, New York Presbyterian-Weill Cornell Medical Center 

Panelist Slides

Harvey Pass, MD, Division of Thoracic Oncology, Perlmutter Cancer Center, New York University Langone Medical Center

Targeted Therapy Trial for Aggressive Early Stage Lung Cancer  

Topic Overview:  Rajwanth Veluswamy, MD, MSCR, Icahn School of Medicine at Mount Sinai


Session Seven: Population Health Metrics – HEDIS & Stars

Topic 1: Lessons from Population Health: How Quality Metrics Work

Introduction from Moderator: Bruce S. Pyenson, FSA, MAAA, Milliman, Inc.

Topic Overviews

Mary Barton, MD, MPP, Performance Measurement, National Committee for Quality Assurance

Robert A. Smith, PhD, Cancer Screening, American Cancer Society and National Lung Cancer Roundtable

Hannah Green, MPH, Health Policy, American Lung Association   

Topic 2: How would Providers and Payers Respond to a Population Health Metric for Lung Cancer Screening?


Virtual Breakout Sessions

The Quantitative Imaging Workshops have hosted discussions on specific topics where there is shared interest in advancing progress. Our process attempts to explore key topics relative to opportunities and challenges. We ask content experts to weigh in on refining issues from their perspectives. From these discussions we look to distill action plans on how we can have the greatest impact on moving a field further. A critical aspect of this process is the vetting of candidate issues by the full assembly of workshop participants which takes place in these breakout sessions.

2020 Topics:

  • Defining and Managing CT Screening Findings of Early Lung Diseases
  • Approach to Advancing Combined Modality Therapy for Early Stage Screen-Detected Disease—Adjuvant/Neoadjuvant Therapy

Day 1 – Joint Session: Breakout Introduction

 

Day 2 – Two Simultaneous Sessions

Topic 1: Defining and Managing CT Screening Findings of Early Lung Diseases

Topic 2: Approach to Advancing Combined Modality Therapy for Early Stage Screen-Detected Disease—Adjuvant/Neoadjuvant Therapy

Questions document

Day 3 – Joint Session: Results & Action Plans

Topic 1: Defining and Managing CT Screening Findings of Early Lung Diseases – Final Summary Slides

Topic 2: Approach to Advancing Combined Modality Therapy for Early Stage Screen-Detected Disease—Adjuvant/Neoadjuvant Therapy – Final Summary document


Return to Quantitative Imaging Workshop main page 

Join now to keep up with the latest in cancer prevention and early detection